Therefore, it was hypothesized that ROS-involved signaling pathways might participate in G6PD dysregulation, perform cross-talk, and form a feedback loop to promote ccRCC tumorigenesis. This evidence concerns the gene G6PD and nonpapillary renal cell carcinoma.